retatrutide fda approval status november 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Will the FDA approve retatrutide?

The current $1,000+ monthly price tags are out of reach for most Americans, and theyre fueling the rise of gray market alternatives

Moderate Reactions Characteristics: Moderate reactions might involve more noticeable rashes, persistent itching, and discomfort

If a patch becomes dislodged, patients should follow the specific guidance provided with their medication or contact their healthcare provider for advice

There is no wrong choice between these medications for most candidates

Microdose semaglutide is $179 and microdose tirzepatide is $269 for a 28-day supply, with async care-team messaging included rather than billed separately.